David A. Siegel Verastem, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.39 - $0.71 $173,706 - $316,234	-445,400 Reduced 42.72%	597,200 $250,000
Q4 2022 Feb 14, 2023	BUY	$0.33 - $10.44 $29,535 - $934,380	89,500 Added 9.39%	1,042,600 $417,000
Q3 2022 Nov 14, 2022	SELL	$0.92 - $11.16 $92,460 - $1.12 Million	-100,500 Reduced 9.54%	953,100 $810,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $578,544 - $1.04 Million	-567,200 Reduced 35.0%	1,053,600 $1.22 Million
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $149,672 - $296,520	-141,200 Reduced 8.01%	1,620,800 $2.29 Million
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $652,925 - $1.02 Million	-318,500 Reduced 15.31%	1,762,000 $3.61 Million
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $121,666 - $194,953	-47,900 Reduced 2.25%	2,080,500 $6.41 Million
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $32,896 - $62,079	12,800 Added 0.61%	2,128,400 $8.66 Million
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $3.37 Million - $5 Million	1,772,900 Added 517.33%	2,115,600 $5.23 Million
Q4 2020 Feb 16, 2021	BUY	$1.15 - $2.4 $394,104 - $822,480	342,700 New	342,700 $730,000
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $101,787 - $154,056	-91,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $154,973 - $385,140	91,700 New	91,700 $158,000
Q4 2019 Feb 14, 2020	SELL	$0.86 - $1.44 $41,710 - $69,840	-48,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.59 $200,013 - $262,827	-165,300 Reduced 77.32%	48,500 $59,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $148,250 - $372,404	-118,600 Reduced 35.68%	213,800 $323,000
Q1 2019 May 15, 2019	BUY	$2.79 - $4.09 $212,319 - $311,249	76,100 Added 29.69%	332,400 $984,000
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $725,781 - $1.58 Million	224,700 Added 711.08%	256,300 $861,000
Q3 2018 Nov 14, 2018	SELL	$6.86 - $9.97 $34,300 - $49,850	-5,000 Reduced 13.66%	31,600 $229,000
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $52,416 - $157,794	-18,200 Reduced 33.21%	36,600 $252,000
Q1 2018 May 15, 2018	SELL	$2.92 - $3.81 $60,152 - $78,486	-20,600 Reduced 27.32%	54,800 $163,000
Q4 2017 Feb 14, 2018	BUY	$2.99 - $4.85 $225,446 - $365,690	75,400	75,400 $231,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.16 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$248,160
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$103,400
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$15,432
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$5,552
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account